New cancer clinical trial: A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers

Published on: June 25, 2018 at 12:00PM
Condition:   Lung Cancer
Interventions:   Drug: Osimertinib;   Drug: Platinum;   Drug: Etoposide
Sponsor:   Memorial Sloan Kettering Cancer Center
Recruiting
https://ift.tt/2N7HNyg